Corcept Therapeutics Incorporated ( CORT) - Stock Earnings
CORT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 19.7 million USD | 207.6 million USD |
| 2025Q4 | 24.3 million USD | 202.1 million USD |
| 2026Q1 | -31.2 million USD | 164.9 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
CORT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 106.1 million USD | 482.4 million USD |
| 2024 | 139.7 million USD | 675.0 million USD |
| 2025 | 99.7 million USD | 761.4 million USD |
| 2026 Est. | — | — |
CORT
Price: $82.75
52 week price:
Earnings Per Share: 0.35 USD
P/E Ratio: 149
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 611800
Ebitda: 13.7 millionMarket Capitalization: 7.8 billion